Before graduating with his doctorate in medicinal chemistry from the College of Pharmacy last August, Brandt Huddle, PhD, played an instrumental role in the development of a new therapeutic compound for cancer, CM39. The compound inhibits the ability of a key enzyme, aldehyde dehydrogenase (ALDH), to promote chemotherapy resistance in a small pool of cells linked to ovarian cancer.
Simone Brixius-Anderko, Medicinal Chemistry Research Fellow, talks about her American Heart Association award – which will support her search for a new way to treat hypertension and associated cardiac disease. She will also discuss serving as a role model for those from non-academic first careers and inspiring a love of science in the next generation of researchers.
Ultimately, Dr. Brixius-Anderko hopes the award will support her search for a new way to treat hypertension and associated cardiac disease. She would also like to serve as a role model to young people, particularly those with non-academic background with a first career, that is it possible to have a family and a scientific career.